Close

Dr Eugene Ruzagira

Associate Professor

United Kingdom

Research

Research Area
Vaccines
Complex interventions
Social and structural determinants of health
Drug discovery and development
Public health
Epidemiology
Medicine
Vaccinology
Disease and Health Conditions
HIV/AIDS
Infectious diseases
Sexually transmitted infections
Country
Uganda
Tanzania
Kenya
South Africa
Rwanda
Mozambique
Zambia
United Kingdom
Region
Sub-Saharan Africa (all income levels)

Selected Publications

Long-Acting HIV Therapy in African Adults with Adherence Challenges.
CRESSWELL, FV; Kitonsa, J; Norcross, C; Tumusiime, V; Ombajo, LA; Garrett, N; Kassim, S; Owarwo, NC; Laker Odongpiny, EA; Yawe, I; Mahomed, S; Mugerwa, H; Kafeero, PL; Nkuranga, J; Bahemuka, U; Nabbuto, J; Ankunda, V; Nabaggala, P; Ogwang, C; Kimbugwe, G; Kakande, A; Singh, U; Van der Vendt, D; Onyango, A; Koile, E; ... IMPALA Study Group,
2026
New England Journal of Medicine
A systematic review of evidence on weight change following initiation of long-acting cabotegravir for the prevention or treatment of HIV.
KITONSA, J; Komata, R; Ssembajjwe, W; GRINT, D; Robinson, J; RUZAGIRA, E; Kalyesubula, R; Vera, J; CRESSWELL, F;
2026
HIV medicine
Persistent gaps in the prevention of mother-to-child HIV transmission in central Uganda: a case-control study.
Lubega, G; Kikaire, B; Mubiru, M; Ankunda, V; Ssembajjwe, W; Bengo, S; Kibirige, M; Lutaakome, J; Kusemererwa, S; ABAASA, A; RUZAGIRA, E;
2026
International health
A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomized, Factorial, Noninferiority Trial.
McCormack, S; Dunn, D; KUSEMERERWA, S; Munseri, P; Singh, N; William, W; MUTONYI, G; Bern, H; Goldwirt, L; Kingsley, C; Kroidl, A; HANSEN, CH; Ding, S; KAWUMA, R; Amondi, M; BAHEMUKA, U; Buma, D; Clutterbuck, D; Gaffoor, Z; Jennings, A; Joachim, A; KAKANDE, A; Kalanzi, B; Kisinda, A; Matsoso, M; ... PrEPVacc Study Group,
2026
J Acquir Immune Defic Syndr
Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East and Southern Africa: a longitudinal qualitative study.
KAWUMA, R; Nakamanya, S; Tarimo, E; Chimukuche, RS; Ambindwile, J; Pamba, D; KUSEMERERWA, S; Munseri, P; Singh, N; Dubé, K; McCormack, S; RUZAGIRA, E; SEELEY, J; PrEPVacc trial team,;
2026
Trials
Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018-2022 HIV vaccine preparedness cohort in Masaka, Uganda
KUSEMERERWA, S; Kansiime, S; MUTONYI, G; KAKANDE, A; Nabukenya, S; Namirembe, A; Erima, N; Asio, DJ; Atuhura, EM; Ssendagire, S; Onyango, M; Fox, J; McCormack, S; KALEEBU, P; RUZAGIRA, E; PrEPVacc Study Team,;
2026
PloS one
The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda.
Stuart, AS; Muhumuza, R; KUSEMERERWA, S; Ndagire, MT; Hill, M; O'Reilly, PJ; Onyango, M; Solomon, W; Akankunda, P; Masawi, S; Ssendagire, S; Murphy, D; Vanderslott, S; Rollier, CS; RUZAGIRA, E; Pollard, AJ; KYEGOMBE, N;
2026
BMC public health
Who is a mobile man 'at risk'? Masculinity, work-related mobility, and HIV-related risks in Uganda and South Africa.
MBONYE, M; SEELEY, J; Fox, J; WEBB, EL; Medina-Marino, A; RUZAGIRA, E; Manyaapelo, T; Ngcobo, SE; Mobile Men Study Team,;
2026
Journal of migration and health
See more information